Bill
SB 25-121
Medicaid Reimbursement for Vagus Nerve Stimulation
2025 Regular Session
Introduced by Judy Amabile and 16 co-sponsors
Medicaid would reimburse facilities 60% of VNS device costs initially (rising to 75% by 2029) for drug-resistant epilepsy patients, in addition to surgical payments.
House Committee on Health & Human Services Postpone Indefinitely